3-Aug-2019: The global computational
biology market size is expected to reach USD 13.6 billion
by 2026, according to a new report by Grand View Research, Inc. It is
anticipated to expand at a CAGR of 21.3% during the forecast period. Rise in
clinical studies in pharmacokinetics and pharmacogenomics for novel drug
delivery and increase in the application of computational biology for
bioinformatics R&D programs for the population based sequencing studies are
fueling the market growth.
Rising use of
computational tools in genomics, epi-genomics, proteomics, and meta-genomics to
understand 3D protein structural analysis, protein-protein interactions, and
gene sequencing and expression studies coupled with increasing research
activities in drug designing and disease modeling is expected to drive the
growth. However, lack of skilled resources to operate computational tools is
expected to restrain the growth of the computational biology market during the
forecast period.
Many pharmaceutical
companies are seeking funding from angel investors. For instance, in February
2019, StemoniX Inc., the U.S. based provider of product and services for drug
discovery and development, received funding of USD 14.40 million from a group
of investors. Brightstone Venture Capital was the major financer and was later
joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic.
Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus
received funding of USD 5.0 million to speed up the discovery of new drugs.
With this finding, the research institute is planning to procure and install
drug discovery research instruments and other drug discovery platforms.
In
depth research report on Computational Biology Market
Further key findings from the report suggest:
·
Cellular and biological simulation is expected to expand at
the fastest CAGR of over 15.0% over the forecast period. The shift in
sequencing studies towards further analysis of the nature of various biological
proteins as a part of the development of personalized medicine, is projected
drive the growth
·
Drug discovery and disease modelling applications led the
market, accounting for 38.0% of the global market in terms of revenue in 2018.
The factors responsible for this growth are extensive drug pipelines for the
global drug manufacturing firms
·
North America was the largest regional market, accounted for
more than 45.0% of the global revenue in 2018. Increase in research activities
for drug discovery processes and innovations in biological computation tools
are anticipated to drive the growth
·
Asia Pacific is anticipated to witness the fastest of around
CAGR of 23.0% during the forecast period, due to increasing expenditure in the
clinical studies for the pharmaco-kinetics and pharmaco-genomics
·
Some of the players operating in the computational biology
market include Chemical Computing Group Inc.; Compugen Ltd.; Simulation Plus
Inc.; Genedata AG; Certara; Insilico Biotechnology AG; Accelrys; Rhenovia
Pharma SAS; Entelos; Nimbus Discovery LLC; and Rhenovia Pharma SAS.
Grand View Research
has segmented the global computational biology market based on application,
service, end use, and region:
Computational Biology Application Outlook (Revenue, USD
Million 2015 - 2026)
·
Cellular & Biological Simulation
o
Computational Genomics
·
Databases
·
Infrastructure/Hardware
·
Software & Services
·
Computational Proteomics
·
Pharmacogenomics
·
Others (Transcriptomics/Metabolomics)
·
Drug Discovery & Disease Modelling
·
Target Identification
·
Target Validation
·
Lead Discovery
·
Lead Optimization
·
Preclinical Drug Development
·
Pharmacokinetics
·
Pharmacodynamics
·
Clinical Trials
·
Phase I
·
Phase II
·
Phase III
·
Human Body Simulation Software
Computational Biology Services Outlook (Revenue, USD Million
2015 - 2026)
·
In-house
·
Contract
Computational Biology End-use Outlook (Revenue, USD Million
2015 - 2026)
·
Academics
·
Industry
·
Commercial
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment